Frec Markets’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1M Sell
7,037
-96
-1% -$14.6K 0.06% 382
2026
Q2
$1.12M Buy
7,133
+871
+14% +$131K 0.1% 205
2026
Q1
$957K Buy
6,262
+1,455
+30% +$223K 0.16% 111
2025
Q4
$663K Buy
+4,807
New +$629K 0.19% 93

Other funds holding NVS

Frec Markets's NVS Position: Q3 2026 in Review

Frec Markets reduced its Novartis (NVS) stake by 1.3% in Q3 2026, selling an estimated $14.6K and leaving 7,037 shares worth $1M. The position accounts for 0.06% of the portfolio, ranked #382.

Frec Markets first reported a position in NVS in Q4 2025 and has held it in 4 quarters since. The position peaked at $1.12M in Q2 2026. 1,560 funds tracked by Wall St. Rank hold NVS as of Q3 2026.

  • Frec Markets held 7,037 shares of Novartis worth $1M as of Q3 2026.
  • Frec Markets sold 96 Novartis shares in Q3 2026, an estimated $14.6K.
  • Novartis made up 0.06% of Frec Markets's portfolio in Q3 2026, its #382 holding.
  • Frec Markets first reported a position in Novartis in Q4 2025 and has held it in 4 quarters since.
  • Frec Markets's Novartis position peaked at $1.12M in Q2 2026.
  • 1,560 funds tracked by Wall St. Rank held Novartis as of Q3 2026.

Based on Frec Markets's 13F filing for Q3 2026, filed 16 Nov 2026.